0001640334-22-000912.txt : 20220906 0001640334-22-000912.hdr.sgml : 20220906 20220505115544 ACCESSION NUMBER: 0001640334-22-000912 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREEN VISION BIOTECHNOLOGY CORP. CENTRAL INDEX KEY: 0001571804 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 981060941 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: ROOMS 1804-06, 18/F, WING ON HOUSE STREET 2: 71 DES VOEUX ROAD CENTRAL CITY: HONG KONG SAR STATE: F4 ZIP: 00000 BUSINESS PHONE: 852-94929967 MAIL ADDRESS: STREET 1: ROOMS 1804-06, 18/F, WING ON HOUSE STREET 2: 71 DES VOEUX ROAD CENTRAL CITY: HONG KONG SAR STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: VIBE WIRELESS CORP. DATE OF NAME CHANGE: 20151116 FORMER COMPANY: FORMER CONFORMED NAME: ANYTRANSLATION CORP DATE OF NAME CHANGE: 20130312 CORRESP 1 filename1.htm gvbt_corresp.htm

 

GREEN VISION BIOTECHNOLOGY CORP.

 

Rooms 1804-06, 18/F, Wing On House, 71 Des Voeux Road Central, Hong Kong

 

Date: May 5, 2022

 

US Securities and Exchange Commission

100 F Street, N.E.

Washington D.C. 20549

U.S.A.

 

Dear Sirs or Madams,

 

Re: GVBT Form 10-K for the year ended December 31, 2021

 

Green Vision Biotechnology Corp. (“GVBT”) received a comment letter from the Securities and Exchange Commission (the “SEC”) related to the filing mentioned above. The SEC requested that GVBT respond to the comments through filing of a 10-K/A by May 16, 2022. GVBT requested an extension to May 30, 2022. The SEC granted such extension. GVBT plans to file the subject 10-K/A on or before May 30, 2022.

 

Should you have any further queries, please do not hesitate to contact the undersigned at +852-2913 9930/+852-9492-9967, or our legal representative in the USA, Mr. Matthew McMurdo, McMurdo Law Group, LLC, at 917-318-2865.   

 

Thank you for your kind attention.

 

Yours sincerely,

 

For and on behalf of GREEN VISION BIOTECHNOLOGY CORP.

 

   
/s/ Lam Ching Wan, William
Lam Ching Wan, William  
Chief Executive Officer  
Encls